119 related articles for article (PubMed ID: 30427274)
1. Comparison of metabolomics and platelet aggregometry between Plavix and generic clopidogrel in cats: a pilot study.
Malkawi M; Woolcock AD; Lee PM; Court MH; Moore GE; Hogan DF
J Feline Med Surg; 2019 Oct; 21(10):951-958. PubMed ID: 30427274
[TBL] [Abstract][Full Text] [Related]
2. Effects of clopidogrel therapy on whole blood platelet aggregation, the Plateletworks® assay and coagulation parameters in cats with asymptomatic hypertrophic cardiomyopathy: a pilot study.
den Toom ML; van Leeuwen MW; Szatmári V; Teske E
Vet Q; 2017 Dec; 37(1):8-15. PubMed ID: 27786603
[TBL] [Abstract][Full Text] [Related]
3. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the ACCEL-GENERIC study.
Jeong YH; Koh JS; Kang MK; Ahn YJ; Kim IS; Park Y; Hwang SJ; Kwak CH; Hwang JY
Korean J Intern Med; 2010 Jun; 25(2):154-61. PubMed ID: 20526388
[TBL] [Abstract][Full Text] [Related]
4. A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel.
Sambu N; Radhakrishnan A; Curzen N
J Cardiovasc Pharmacol; 2012 Dec; 60(6):495-501. PubMed ID: 23232787
[TBL] [Abstract][Full Text] [Related]
5. Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Effective?
Westphal ES; Aladeen T; Vanini D; Rainka M; McCadden K; Gengo FM; Bates V
J Pharm Pract; 2022 Aug; 35(4):536-540. PubMed ID: 33648379
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the antiplatelet effect of two clopidogrel bisulfate formulations: Plavix and generic-Egitromb.
Komosa A; Siller-Matula JM; Kowal J; Lesiak M; Siniawski A; Mączyński M; Michalak M; Mularek-Kubzdela T; Grajek S
Platelets; 2015; 26(1):43-7. PubMed ID: 24499166
[TBL] [Abstract][Full Text] [Related]
7. Influence of a low dosage of clopidogrel on platelet function in cats as measured by the platelet function analyser PFA-100 and the multiplate analyser.
Teuber M; Mischke R
Res Vet Sci; 2016 Dec; 109():149-156. PubMed ID: 27892864
[TBL] [Abstract][Full Text] [Related]
8. Plateletworks: a screening assay for clopidogrel therapy monitoring in healthy cats.
Hamel-Jolette A; Dunn M; Bédard C
Can J Vet Res; 2009 Jan; 73(1):73-6. PubMed ID: 19337399
[TBL] [Abstract][Full Text] [Related]
9. Comparison of original and generic clopidogrel 600 mg loading dose in the patients who planned undergoing coronary angiography.
Srimahachota S; Rojnuckarin P; Udayachalerm W; Buddhari W; Chaipromprasit J; Lertsuwunseri V; Akkawat B; Jirapattrathamrong S
J Med Assoc Thai; 2012 Dec; 95(12):1495-500. PubMed ID: 23390778
[TBL] [Abstract][Full Text] [Related]
10. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
[TBL] [Abstract][Full Text] [Related]
11. Platelet Activation and Clopidogrel Effects on ADP-Induced Platelet Activation in Cats with or without the A31P Mutation in MYBPC3.
Li RH; Stern JA; Ho V; Tablin F; Harris SP
J Vet Intern Med; 2016 Sep; 30(5):1619-1629. PubMed ID: 27615120
[TBL] [Abstract][Full Text] [Related]
12. Relationship between pharmacokinetics and pharmacodynamics of clopidogrel in patients undergoing percutaneous coronary intervention: comparison between vasodilator-stimulated phosphoprotein phosphorylation assay and multiple electrode aggregometry.
Danese E; Fava C; Beltrame F; Tavella D; Calabria S; Benati M; Gelati M; Gottardo R; Tagliaro F; Guidi GC; Cattaneo M; Minuz P
J Thromb Haemost; 2016 Feb; 14(2):282-93. PubMed ID: 26576037
[TBL] [Abstract][Full Text] [Related]
13. Doubling the clopidogrel dose in patients with reduced responsiveness to the standard dose is associated with a limited effectiveness as evaluated by impedance aggregometry.
Stellbaum C; Ayral Y; Morguet A; Schultheiss HP; Rauch U
Cardiovasc Revasc Med; 2012; 13(3):159-66. PubMed ID: 22503564
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats.
Lo ST; Li RHL; Georges CJ; Nguyen N; Chen CK; Stuhlmann C; Oldach MS; Rivas VN; Fousse S; Harris SP; Stern JA
J Vet Intern Med; 2023; 37(4):1390-1400. PubMed ID: 37208839
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and pharmacokinetic evaluation of clopidogrel and the carboxylic acid metabolite SR 26334 in healthy dogs.
Brainard BM; Kleine SA; Papich MG; Budsberg SC
Am J Vet Res; 2010 Jul; 71(7):822-30. PubMed ID: 20594086
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
Platelets; 2004 Aug; 15(5):325-32. PubMed ID: 15370104
[TBL] [Abstract][Full Text] [Related]
17. Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC19*2 and *3.
Wójcik T; Szymkiewicz P; Ściborski K; Łukaszewski M; Onisk G; Mysiak A; Gamian A; Wiśniewski J; Dobosz T; Lebioda A; Jonkisz A; Protasiewicz M
Adv Clin Exp Med; 2021 May; 30(5):485-489. PubMed ID: 33974752
[TBL] [Abstract][Full Text] [Related]
18. Clinical bioequivalence of a dose of clopidogrel Leti Cravid tablets 75 mg versus clopidogrel Sanofi Plavix tablets 75 mg administered on a daily dose for 7 days on healthy volunteers: a clinical trial.
Müller A; Octavio J; González MY; Contreras J; Méndez G; Portillo M; Valero Z
Am J Ther; 2010; 17(3):351-6. PubMed ID: 20019589
[TBL] [Abstract][Full Text] [Related]
19. How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification.
Neubauer H; Lask S; Engelhardt A; Mügge A
Thromb Haemost; 2008 Feb; 99(2):357-62. PubMed ID: 18278186
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
